Compare
5 stocks, side by sideRelative performance · rebased to 100
GLUETYRARAPPMESOTSHA
| GLUEMonte Rosa Therapeutics, Inc. | TYRATyra Biosciences, Inc. | RAPPRapport Therapeutics, Inc. | MESOMesoblast Limited | TSHATaysha Gene Therapies, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 2/10 | 4/10 | 9/10 | 5/10 | 4/10 |
| Price | $14.28 | $26.72 | $45.98 | $16.40 | $5.48 |
| 1 month | -9.2% | -0.45% | -0.84% | +5.0% | -14% |
| 1 year | +213% | +147% | +215% | +3.0% | +87% |
| 5 year | -57% | - | - | +9.8% | -69% |
| P/E (TTM) | - | -12.3 | -17.7 | -74.3 | -14.4 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.8B | $1.8B | $1.9B | $1.9B | $1.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.